Academician
AYŞE HALE ALKAN
ARAŞTIRMA GÖREVLİSİ
ANKARA ÜNİVERSİTESİ BİYOTEKNOLOJİ ENSTİTÜSÜ BİYOTEKNOLOJİ ANABİLİM DALI
- Ana Dal Fen Bilimleri ve Matematik Temel Alanı
- Yan Dal Moleküler Biyoloji ve Genetik
A quick look at recorded outputs — details below.
- Articles 5
- Projects 0
- Books 0
- Proceedings 4
- Patents 0
- Artistic 0
Scopus (SJR)
Q1
4
Q2
3
Q3
0
Q4
0
WoS (JCR)
Q1
2
Q2
5
Q3
0
Q4
0
TR Index
0
articles
Field+year+type normalized OpenAlex percentiles — not Clarivate ESI / SciVal.
Top 1% articles
0
Top 10% articles
2
Avg percentile
69.5%
Top 1% share
0.0%
Top 10% share
28.6%
Articles
Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.
Article list
- 2025 Evernic Acid: A Low‐Toxic and Selective Alternative to Chemotherapeutic Agents in the Treatment of Ovarian Cancer YÖKSİS SJR Q2 JCR Q2 OpenAlex 68.8%
- 2025 Multifaceted interactions between lncRNA-associated ceRNA networks and small molecules in triple-negative breast cancer YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 95.8%
- 2024 To Elucidate the Effective Role of Small Molecule Regulated lncRNAs in the Tumour Microenvironment in Immunotherapy YÖKSİS SJR Q2 JCR Q2 OpenAlex 11.4%
- 2024 A new therapeutic strategy for luminal A-breast cancer treatment: vulpinic acid as an anti-neoplastic agent induces ferroptosis and apoptosis mechanisms YÖKSİS SJR Q1 JCR Q2 OpenAlex 81.8%
- 2023 Strategic and Innovative Roles of lncRNAs Regulated by Naturally-Derived Small Molecules in Cancer Therapy YÖKSİS SJR Q1 JCR Q2 OpenAlex 64.4%
- 2025 Multifaceted interactions between lncRNA-associated ceRNA networks and small molecules in triple-negative breast cancer YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 95.7%
- 2025 Evernic Acid: A Low‐Toxic and Selective Alternative to Chemotherapeutic Agents in the Treatment of Ovarian Cancer YÖKSİS SJR Q2 JCR Q2 OpenAlex 68.8%